BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 26014094)

  • 1. Hypercoagulability in adolescent girls on oral contraceptives-global coagulation profile and estrogen receptor polymorphisms.
    Zia A; Callaghan MU; Callaghan JH; Sawni A; Bartlett H; Backos A; Marshall S; Chitlur M; Rajpurkar M
    Am J Hematol; 2015 Aug; 90(8):725-31. PubMed ID: 26014094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased factor VIII plays a significant role in plasma hypercoagulability phenotype of patients with cirrhosis.
    Sinegre T; Duron C; Lecompte T; Pereira B; Massoulier S; Lamblin G; Abergel A; Lebreton A
    J Thromb Haemost; 2018 Jun; 16(6):1132-1140. PubMed ID: 29577605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of procoagulant imbalance. Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin.
    Tripodi A
    Thromb Haemost; 2017 May; 117(5):830-836. PubMed ID: 28229158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial.
    Johnson JV; Lowell J; Badger GJ; Rosing J; Tchaikovski S; Cushman M
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):278-84. PubMed ID: 18238963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercoagulability following major partial liver resection - detected by thrombomodulin-modified thrombin generation testing.
    Potze W; Alkozai EM; Adelmeijer J; Porte RJ; Lisman T
    Aliment Pharmacol Ther; 2015 Jan; 41(2):189-98. PubMed ID: 25382796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns.
    Hyytiäinen S; Wartiovaara-Kautto U; Ulander VM; Kaaja R; Heikinheimo M; Petäjä J
    Thromb Haemost; 2006 Mar; 95(3):434-40. PubMed ID: 16525570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood thrombin generation shows a significant hypocoagulable state in patients with decompensated cirrhosis.
    Zanetto A; Campello E; Bulato C; Willems R; Konings J; Roest M; Gavasso S; Nuozzi G; Toffanin S; Zanaga P; Burra P; Russo FP; Senzolo M; de Laat B; Simioni P
    J Thromb Haemost; 2024 Feb; 22(2):480-492. PubMed ID: 37866518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
    Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.
    Szanto T; Nummi V; Jouppila A; Brinkman HJM; Lassila R
    Platelets; 2020; 31(1):103-111. PubMed ID: 30836803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G; Curvers J; Middeldorp S; Thomassen MC; Meijers JC; Prins MH; Bouma BN; Büller HR; Rosing J
    Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis.
    Anžej Doma S; Vučnik M; Božič Mijovski M; Peternel P; Stegnar M
    Thromb Res; 2013 Nov; 132(5):621-6. PubMed ID: 24083963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin generation reveals high procoagulant potential in the plasma of sickle cell disease children.
    Noubouossie DF; Lê PQ; Corazza F; Debaugnies F; Rozen L; Ferster A; Demulder A
    Am J Hematol; 2012 Feb; 87(2):145-9. PubMed ID: 22052675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.
    Segers O; Simioni P; Tormene D; Castoldi E
    Thromb Haemost; 2014 Mar; 111(3):438-46. PubMed ID: 24226152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of levonorgestrel contraceptive implants, Norplant, on blood coagulation.
    Shaaban MM; Elwan SI; el-Kabsh MY; Farghaly SA; Thabet N
    Contraception; 1984 Nov; 30(5):421-30. PubMed ID: 6440738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparanase procoagulant activity is elevated in women using oral contraceptives.
    Matan M; Axelman E; Brenner B; Nadir Y
    Hum Reprod; 2013 Sep; 28(9):2372-80. PubMed ID: 23800622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The haemostatic system in acromegaly: a single-centre case-control study.
    Campello E; Marobin M; Barbot M; Radu CM; Voltan G; Spiezia L; Gavasso S; Ceccato F; Scaroni C; Simioni P
    J Endocrinol Invest; 2020 Jul; 43(7):1009-1018. PubMed ID: 31994012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.